Path: utzoo!news-server.csri.toronto.edu!cs.utexas.edu!sun-barr!olivea!uunet!zaphod.mps.ohio-state.edu!usc!elroy.jpl.nasa.gov!ucla-cs!usenet
From: hlaufman@magnus.ircc.ohio-state.edu (Harry B Laufman)
Newsgroups: sci.med.aids
Subject: Re: ibogaine
Message-ID: <1991Mar4.215537.22003@cs.ucla.edu>
Date: 4 Mar 91 21:47:08 GMT
References: <1991Mar4.200457.16283@cs.ucla.edu>
Sender: news@magnus.ircc.ohio-state.edu
Organization: The Ohio State University
Lines: 13
Approved: phil@wubios.wustl.edu
Note: non-commercial reproduction.
Nntp-Posting-Host: squid.cs.ucla.edu
Archive-Number: 3051

In article <1991Mar4.200457.16283@cs.ucla.edu> diggins@husc4.harvard.edu (Lenard Diggins) writes:
>Hi folk,
>    I would appreciate *any* information on ibogaine.  It can
[...]

Ibogaine extracts are said to be used by certain African hunters enabling
them to remain motionless for up to two days and yet maintain mental
acuity.  The Merck Index also cautions of "serious psychological
disturbances" which may account for where I first heard of Ibogaine,
a Hunter S. Thompson piece.  Ibogaine is from the shrub Tabernanthe
iboga (thats two words).  Its therapeutic category is anti-
depressant.  Neuropharmocological study mentioned is SCHNEIDER,
SIGG, Ann. N.Y. Acad. Sci. 66, 765 (1957).